Identification reagent composition for mouse fibroblast subpopulation and use method of identification reagent composition

Through the identification reagent composition of mouse fibroblast subpopulations, using labeled antibodies and flow cytometry, DCN-positive fibroblasts in lung tissues of ARDS mice were successfully identified and sorted, solving the problem of lack of identification methods and promoting ARDS research and treatment direction.

CN119001096AActive Publication Date: 2024-11-22NINGXIA MEDICAL UNIVERSITY GENERAL HOSPITAL
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411197609.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-11-22
Estimated Expiration
2044-08-29

AI Technical Summary

Technical Problem

The lack of effective methods for identifying and sorting DCN-positive fibroblast subpopulations limits clinical and translational studies of ARDS.

Method used

A reagent composition for identification of a subpopulation of mouse fibroblasts, including antigen blocking solution, allophycocyanin-labeled Ly6C antibody, phycoerythrin-labeled CyclinD1 antibody, and fluorescein isothiocyanate-labeled DCN antibody, by Flow cytometry detection and sorting technology enables identification and sorting of DCN-positive fibroblast subpopulations in lung tissues of ARDS mice.

Benefits of technology

Rapid, simplified and efficient identification and sorting of DCN-positive fibroblast subpopulations, in-depth study of their roles and mechanisms in ARDS, and provide potential targets for clinical treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119001096A_ABST
    Figure CN119001096A_ABST
Patent Text Reader

Abstract

The invention discloses an identification reagent composition for a mouse fibroblast subgroup and a use method thereof, and relates to the technical field of cells, the reagent composition comprises an antigen confining liquid, an allophycocyanin (APC) labeled Ly6C antibody, a phycoerythrin (PE) labeled CyclinD1 antibody, a fluorescein isothiocyanate (FITC) labeled DCN antibody, a PBS phosphate buffer, a cell digestive juice and a red blood cell lysis buffer. The method can be used for identifying and sorting DCN positive fibroblast subgroups in lung tissues of mice with acute lung injury, or identifying and sorting DCN positive fibroblast subgroups in tissue injury or repair in the lung tissues of the mice with acute lung injury; conditions are provided for deeply researching the action and mechanism of DCN positive fibroblasts in ARDS and exploring clinical treatment or prognosis targets.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of cell technology, and in particular to an identification reagent composition for mouse fibroblast subpopulations and a use method thereof. Background Art

[0002] Acute respiratory distress syndrome (ARDS) is a heterogeneous disease characterized by increased alveolar-capillary permeability and lung water content caused by various pathogenic factors such as infection, trauma and shock, with persistent hypoxemia as the prominent feature. The pathogenesis is complex and has not yet been fully elucidated. At present, the diagnosis of ARDS mainly relies on clinical guidelines and imaging examinations. The existing examination methods have poor specificity and low accuracy. ARDS lacks specific treatment methods. The biological heterogeneity of ARDS patients has resulted in its treatment being limited to the organ support level. The mortality rate is as high as 40%, and its pathogenesis and diagnostic and therapeutic targets still require a lot of in-depth research. Therefore, studying new targets or molecular markers and further exploring their regulatory mechanisms in immune response are of great significance for the clinical prevention and treatment of ARDS.

[0003] Fibroblasts play a key role in the pathological process of ARDS. They play an important role in inflammatory response, tissue repair and alveolar structural remodeling. The connection between early activation of ARDS and the development of pulmonary fibrosis has been confirmed. Fibroblasts regulate the lung microenvironment by producing ECM remodeling enzymes, such as ADAMTS4, affecting the infiltration and function of immune cells, and thus affecting the course of ARDS. In addition, fibroblasts play an important role in lung repair after injury, and their abnormal activation is associated with poor prognosis in patients. Foreign studies have further explored the interaction between fibroblasts and immune cells and their synergistic effect in the progression of ARDS. With the development of single-cell sequencing technology, cell subpopulations have received widespread attention from researchers. Various cell subpopulations formed by differentiation of cell groups during the occurrence and development of the disease have been proven to play an important role in the occurrence and development of the disease, but the induction of these cell subpopulations by in vitro cultured cell lines is complex, so the function of these cells cannot be further studied. The role of fibroblasts in acute lung injury and its role as a drug target to reduce lung tissue inflammation and promote tissue repair deserve further study. The obstacle that limits its clinical and translational research is the lack of identification and sorting methods for fibroblast subpopulations that are highly related to ARDS. Cell membrane surface antigens are the cell's identity code. Through cell membrane surface antigen identification, cells can be classified into types, groups, and subpopulations. Single-cell sequencing technology can help us find cell subpopulations that uniquely express a certain type of antigen in a cell group, providing conditions for studying the relationship between these subpopulations and diseases.

[0004] The present invention team conducted single-cell sequencing on the lung tissue of ARDS model mice induced by lipopolysaccharide (LPS) and discovered a special fibroblast population in the lung tissue of ARDS mice, which is closely related to the damage and repair function of lung tissue in ARDS. Since this subpopulation uniquely expresses DCN on the cell membrane surface, we named it the DCN-positive fibroblast subpopulation. At present, there is no method for identifying and sorting DCN-positive fibroblast subpopulations. Based on this, a reagent composition for identifying mouse fibroblast subpopulations and a method for using the same are proposed. Summary of the invention

[0005] The present invention is intended to provide a mouse fibroblast subpopulation identification reagent composition and a method of using the same, so as to solve the problem that there is currently no method for identifying and sorting DCN-positive fibroblast subpopulations.

[0006] In order to achieve the above object, the present invention provides the following technical solutions:

[0007] A reagent composition for identifying mouse fibroblast subpopulations comprises 10-20 ml of antigen blocking solution, 30-50 μL of Ly6C antibody labeled with allophycocyanin (APC), 30-50 μL of CyclinD1 antibody labeled with phycoerythrin (PE), 30-50 μL of DCN antibody labeled with fluorescein isothiocyanate (FITC), 50-80 ml of PBS phosphate buffer, 40-60 ml of cell digestion solution and 50-80 ml of red blood cell lysis solution, wherein all reagents are individually packed into sterile sealed bottles.

[0008] Furthermore, the antigen blocking solution is prepared into a liquid with a mass / concentration of 1% using bovine serum albumin and PBS phosphate buffer, and then filtered through a 0.22 micron filter membrane and then packaged.

[0009] Furthermore, the PBS phosphate buffer, cell digestion solution and red blood cell lysis solution were all stored at -4°C, and the antigen blocking solution (10 ml), Ly6C antibody A labeled with allophycocyanin (APC), CyclinD1 antibody B labeled with phycoerythrin (PE) and DCN antibody C labeled with fluorescein isothiocyanate (FITC) were all stored at -20°C.

[0010] A method for using a mouse fibroblast subpopulation identification reagent composition, identifying and sorting ARDS mouse lung tissue fibroblast subpopulations, comprising the following steps:

[0011] S1. Remove lung tissue from mice;

[0012] S2. Use PBS phosphate buffer to rinse and remove blood from the surface of mouse lung tissue;

[0013] S3, cut the mouse lung tissue into pieces and place it in the center of the cell sieve, then add the cell digestion solution and grind the mouse lung tissue until it cannot be ground anymore, and collect it to make a cell suspension;

[0014] S4, add cell digestion solution to the cell suspension again, and digest at 40 rpm for 45 min at 37°C;

[0015] S5. Centrifuge the cell suspension at 1000-2000g for 10 min at room temperature, collect the cell pellet, and wash once with 2 mL of phosphate buffer;

[0016] S6. Discard the supernatant, add red blood cell lysis buffer, lyse red blood cells at 4°C for 15 min, collect cells by centrifugation, and resuspend in PBS phosphate buffer to prepare a cell resuspension solution;

[0017] S7, take 1-1.5mL of cell resuspension, use 100-150μL of antigen blocking solution to block for 30min at room temperature, and mix by inverting every 10min;

[0018] S8. Dilute the Ly6C antibody labeled with allophycocyanin (APC) and the DCN antibody labeled with fluorescein isothiocyanate (FITC) with antigen blocking solution at a ratio of 1:50 to prepare the antibody working solution. Add 100-150 μL of the prepared working solution to the cell resuspension solution and stain at 4°C in the dark for 1 h.

[0019] S9, centrifuge the cell resuspension at 2000 rpm for 10 min, discard the supernatant, wash once with PBS phosphate buffer, and finally resuspend again with 1-1.5 mL PBS phosphate buffer as a sample detection solution, and detect and analyze by flow cytometry, using Ly6C antibody labeled with allophycocyanin (APC) as a fibroblast population marker, and using DCN antibody labeled with fluorescein isothiocyanate (FITC) as a fibroblast subpopulation marker;

[0020] S10. Using Ly6C antibody and DCN antibody positivity as markers, use a flow cytometer to collect cells that are positive for Ly6C antibody and DCN antibody, and thus the DCN-positive fibroblast subpopulation can be collected.

[0021] Furthermore, the steps of identifying and sorting lung tissue fibroblast subpopulations of ARDS mice in damaged and repaired states are different in that, in step S8, allophycocyanin (APC)-labeled Ly6C antibody, phycoerythrin (PE)-labeled CyclinD1 antibody and fluorescein isothiocyanate (FITC)-labeled DCN antibody are diluted with antigen blocking solution at a ratio of 1:50 to prepare an antibody working solution.

[0022] Furthermore, the steps of identifying and sorting fibroblast subpopulations in the lung tissue of ARDS mice in a state of damage and repair are different in that, in step S9, Ly6C antibody labeled with allophycocyanin (APC) is used as a fibroblast population marker, CyclinD1 antibody labeled with phycoerythrin (PE) is used as a damage and repair marker, and DCN antibody labeled with fluorescein isothiocyanate (FITC) is used as a fibroblast subpopulation marker.

[0023] Furthermore, the steps of identifying and sorting fibroblast subpopulations in lung tissue of ARDS mice in damaged and repaired states are different in that, in step S10, Ly6C antibody, CyclinD1 antibody and DCN antibody positivity are used as markers, and cells positive for Ly6C antibody, CyclinD1 antibody and DCN antibody are collected using a flow cytometer collection tube.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] 1. The present invention constructs a fibroblast identification and sorting reagent composition by combining Ly6C antibody labeled with allophycocyanin (APC), CyclinD1 antibody labeled with phycoerythrin (PE) and DCN antibody labeled with fluorescein isothiocyanate (FITC). It can identify and sort DCN-positive fibroblast subpopulations in the lung tissue of mice with acute lung injury, or identify and sort DCN-positive fibroblast subpopulations in tissue damage or repair in the lung tissue of mice with acute lung injury. It provides conditions for in-depth study of the role and mechanism of DCN-positive fibroblasts in ARDS and exploration of clinical treatment or prognosis targets.

[0026] 2. The reagent and antibody combination provided by the present invention can relatively simplify the identification steps, and quickly, conveniently and efficiently identify and sort DCN-positive fibroblasts.

[0027] 3. The present invention can achieve: 1. Identify the state of lung injury in ARDS mice; 2. Identify whether DCN-positive fibroblasts appear in lung injury in ARDS mice, that is, whether tissue damage repair is in progress; 3. Sorting and obtaining DCN-positive fibroblasts; 4. Sorting and obtaining DCN-positive fibroblast subpopulations in damage repair. It has important significance for research in related fields. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 A schematic diagram of the structure of a reagent composition for identifying mouse fibroblast subpopulations;

[0029] Figure 2 Schematic diagram of flow cytometry identification of DCN-positive fibroblast subpopulations in lung tissue of ARDS mice;

[0030] Figure 3 Schematic diagram of flow cytometry identification of DCN fibroblast subpopulations in damaged and repaired states in the lung tissue of ARDS mice. DETAILED DESCRIPTION

[0031] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments:

[0032] Example 1

[0033] A reagent composition for identifying mouse fibroblast subpopulations comprises 10 ml of antigen blocking solution, 30 μL of Ly6C antibody labeled with allophycocyanin (APC), 30 μL of CyclinD1 antibody labeled with phycoerythrin (PE), 30 μL of DCN antibody labeled with fluorescein isothiocyanate (FITC), 50 ml of PBS phosphate buffer (10×), 40 ml of cell digestion solution and 50 ml of red blood cell lysis solution, all of which are individually packed into sterile sealed bottles.

[0034] Example 2

[0035] like Figure 1 As shown, a method for using a mouse fibroblast subpopulation identification reagent composition, which includes the following steps in identifying and sorting DCN-positive fibroblast subpopulations in lung tissue of ARDS mice:

[0036] S1. ARDS mice with mild lung injury were induced by airway perfusion of LPS at a concentration of 0.3 mg / kg, and ARDS mice with severe lung injury were induced by airway perfusion of LPS at a concentration of 1.25 mg / kg. Untreated healthy mice were used as controls. The mice were euthanized by asphyxiation, and the experiment was performed on a sterile clean bench irradiated with ultraviolet light for 30 minutes. The mice were disinfected with 75% ethanol, and the chest cavity was opened with sterile surgical scissors, and the airway and lung tissues were completely removed.

[0037] S2. Use PBS phosphate buffer to rinse and remove blood from the surface of mouse lung tissue;

[0038] S3. Cut the mouse lung tissue into small pieces with dissecting scissors and place the mouse lung tissue in the center of the cell sieve. Add 1 mL of cell digestion solution and grind the tissue with a syringe stopper until it cannot be ground anymore (3-5 minutes). Collect the mixture into a 15 mL centrifuge tube to prepare a cell suspension.

[0039] S4. Add 2 mL of cell digestion solution to the cell suspension again and digest at 40 rpm for 45 min at 37°C.

[0040] S5. Centrifuge the cell suspension at 1000-2000g for 10 min at room temperature, collect the cell pellet, and wash once with 2 mL of phosphate buffer;

[0041] S6. Discard the supernatant, add 2 mL of red blood cell lysis buffer, lyse the red blood cells at 4°C for 15 min, collect the cells by centrifugation, and resuspend them in PBS phosphate buffer to prepare a cell resuspension solution;

[0042] S7, take 1.5mL of cell resuspension and place it in an EP tube, use 150μL of antigen blocking solution to block for 30min at room temperature, and mix by inverting every 10min;

[0043] S8. Dilute the Ly6C antibody labeled with allophycocyanin (APC) and the DCN antibody labeled with fluorescein isothiocyanate (FITC) with antigen blocking solution at a ratio of 1:50 to prepare the antibody working solution. Add 150 μL of the prepared working solution to the cell resuspension solution and stain at 4°C in the dark for 1 h.

[0044] S9, centrifuge the cell resuspension at 2000 rpm for 10 min, discard the supernatant, wash once with PBS phosphate buffer, and finally resuspend again with 1 mL PBS phosphate buffer as a sample detection solution, and analyze by flow cytometry, using allophycocyanin (APC)-labeled Ly6C antibody as a fibroblast population marker, and using fluorescein isothiocyanate (FITC)-labeled DCN antibody as a fibroblast subpopulation marker;

[0045] S10. Using healthy mice as negative controls, cell sorting and collection can be set up while identifying cells. Ly6C antibody and DCN antibody positivity are used as markers. Ly6C antibody and DCN antibody-positive cells are collected using flow cytometry collection tubes to collect DCN-positive fibroblast subpopulations.

[0046] like Figure 2 As shown, the number 1 is the ordinate, which indicates the positive status of Ly6C antibody labeled with phycocyanin (APC), and the number of positive cells increases from bottom to top; the numbers 2, 3 and 4 are the abscissas, which are DCN antibody labeled with fluorescein isothiocyanate (FITC) in healthy mice (2), DCN antibody labeled with fluorescein isothiocyanate (FITC) in ARDS mice with mild lung injury (3), and DCN antibody labeled with fluorescein isothiocyanate (FITC) in ARDS mice with severe lung injury (4), and the number of positive cells increases from left to right. Therefore, the cells in the black box in the upper right corner are Ly6C antibody-positive and DCN antibody-positive cells, which are identified as DCN fibroblast subpopulations. It can be seen that the number of such cells is less in healthy mice (2), but significantly increased in mice with lung injury, and increased with the severity of injury (3,4). Ly6C antibody-positive and DCN antibody-positive cells are collected using flow cytometric collection tubes to obtain DCN fibroblast subpopulations. The reagent composition can stain up to 2×10 7cells, and the DCN fibroblast subpopulation accounted for 34.1%, that is, a maximum of 0.68×10 7 DCN-positive fibroblast subsets.

[0047] Example 3

[0048] like Figure 1 As shown, a method for using a mouse fibroblast subpopulation identification reagent composition, which includes the following steps in identifying and sorting lung tissue fibroblast subpopulations of ARDS mice in a damaged and repaired state:

[0049] S1. ARDS mice with mild lung injury were induced by airway perfusion of LPS at a concentration of 0.3 mg / kg, and ARDS mice with severe lung injury were induced by airway perfusion of LPS at a concentration of 1.25 mg / kg. Untreated healthy mice were used as controls. The mice were euthanized by asphyxiation, and the experiment was performed on a sterile clean bench irradiated with ultraviolet light for 30 minutes. The mice were disinfected with 75% ethanol, and the chest cavity was opened with sterile surgical scissors, and the airway and lung tissues were completely removed.

[0050] S2. Use PBS phosphate buffer to rinse and remove blood from the surface of mouse lung tissue;

[0051] S3. Cut the mouse lung tissue into small pieces with dissecting scissors and place the mouse lung tissue in the center of the cell sieve. Add 1 mL of cell digestion solution and grind the tissue with a syringe stopper until it cannot be ground anymore (3-5 minutes). Collect the mixture into a 15 mL centrifuge tube to prepare a cell suspension.

[0052] S4. Add 2 mL of cell digestion solution to the cell suspension again and digest at 40 rpm for 45 min at 37°C.

[0053] S5. Centrifuge the cell suspension at 1000-2000g for 10 min at room temperature, collect the cell pellet, and wash once with 2 mL of phosphate buffer;

[0054] S6. Discard the supernatant, add 2 mL of red blood cell lysis buffer, lyse the red blood cells at 4°C for 15 min, collect the cells by centrifugation, and resuspend them in PBS phosphate buffer to prepare a cell resuspension solution;

[0055] S7, take 1.5mL of cell resuspension and place it in an EP tube, use 150μL of antigen blocking solution to block for 30min at room temperature, and mix by inverting every 10min;

[0056] S8. Dilute the Ly6C antibody labeled with allophycocyanin (APC), the CyclinD1 antibody labeled with phycoerythrin (PE), and the DCN antibody labeled with fluorescein isothiocyanate (FITC) with antigen blocking solution at a ratio of 1:50 to prepare the antibody working solution. Add 150 μL of the prepared working solution to the cell resuspension solution and stain at 4°C in the dark for 1 h.

[0057] S9, centrifuge the cell resuspension at 2000 rpm for 10 min, discard the supernatant, wash once with PBS phosphate buffer, and finally resuspend again with 1 mL of PBS phosphate buffer as a sample test solution, and detect and analyze by flow cytometry, using allophycocyanin (APC)-labeled Ly6C antibody as a fibroblast population marker, using phycoerythrin (PE)-labeled CyclinD1 antibody as a damage and repair marker, and using fluorescein isothiocyanate (FITC)-labeled DCN antibody as a fibroblast subpopulation marker;

[0058] S10. Using healthy mice as negative controls, cell sorting and collection can be set up while identifying cells. Ly6C antibody, CyclinD1 antibody and DCN antibody positivity are used as markers. Cells positive for Ly6C antibody, CyclinD1 antibody and DCN antibody are collected using flow cytometry collection tubes to collect DCN-positive fibroblast subpopulations.

[0059] like Figure 3 As shown in the diagram, number 1 is the ordinate, indicating the positive status of Ly6C antibody labeled with phycocyanin (APC), and the number of positive cells increases from bottom to top; numbers 2, 3 and 4 are the abscissas, which are CyclinD1 antibody labeled with phycoerythrin (PE) of healthy mice (2), CyclinD1 antibody labeled with phycoerythrin (PE) of ARDS mice with mild lung injury (3), and CyclinD1 antibody labeled with phycoerythrin (PE) of ARDS mice with severe lung injury (4), and the number of positive cells increases from left to right. Since the DCN cell subpopulation has been identified in the first labeling, the DCN cell subpopulation that is positive for damage and repair markers can be directly labeled in the second round of labeling. Therefore, the cells in the black box in the upper right corner are Ly6C antibody-positive, CyclinD1 antibody-positive, and DCN antibody-positive cells, that is, DCN fibroblast subpopulations identified as being in a state of damage and repair. It can be seen that this cell is less in healthy mice (2), and significantly increased in mice with lung injury, and increased with the severity of injury (3,4). Ly6C antibody-positive, CyclinD1 antibody-positive, and DCN antibody-positive cells are collected using a flow cytometer to obtain DCN fibroblasts in a state of damage and repair. This reagent composition can sort out up to 0.68×10 7DCN-positive fibroblast subpopulations were obtained, of which 68% were DCN fibroblasts in the damaged and repaired state, that is, a maximum of 0.46×10 7 DCN fibroblasts in states of injury and repair.

[0060] The above is only an embodiment of the present invention, and the common knowledge such as the known specific technical solutions and / or characteristics in the solution is not described in detail here. It should be pointed out that for those skilled in the art, without departing from the technical solution of the present invention, several modifications and improvements can be made, which should also be regarded as the protection scope of the present invention, and these will not affect the effect of the implementation of the present invention and the practicality of the patent. The scope of protection required by this application shall be based on the content of its claims, and the specific implementation methods and other records in the specification can be used to interpret the content of the claims.

Claims

1. A reagent composition for identifying mouse fibroblast subpopulations, characterized in that: It includes 10-20 ml of antigen blocking solution, 30-50 μL of allophycocyanin (APC)-labeled Ly6C antibody, 30-50 μL of phycoerythrin (PE)-labeled CyclinD1 antibody, 30-50 μL of fluorescein isothiocyanate (FITC)-labeled DCN antibody, 50-80 ml of PBS phosphate buffer, 40-60 ml of cell digestion solution and 50-80 ml of red blood cell lysis solution. All reagents are individually packed in sterile sealed bottles.

2. A reagent composition for identifying mouse fibroblast subpopulations, characterized in that: The antigen blocking solution is prepared into a liquid with a mass / concentration of 1% using bovine serum albumin and PBS phosphate buffer, and then filtered through a 0.22 micron filter membrane before being packaged.

3. A reagent composition for identifying mouse fibroblast subpopulations, characterized in that: The PBS phosphate buffer, cell digestion solution and red blood cell lysis solution were all stored at -4°C, and the antigen blocking solution (10 ml), Ly6C antibody A labeled with allophycocyanin (APC), CyclinD1 antibody B labeled with phycoerythrin (PE) and DCN antibody C labeled with fluorescein isothiocyanate (FITC) were all stored at -20°C.

4. A method for using a reagent composition for identifying mouse fibroblast subpopulations, characterized in that: Identification and sorting of fibroblast subpopulations in lung tissue of ARDS mice includes the following steps: S1. Remove lung tissue from mice; S2. Use PBS phosphate buffer to rinse and remove blood from the surface of mouse lung tissue; S3, cut the mouse lung tissue into pieces and place it in the center of the cell sieve, then add the cell digestion solution and grind the mouse lung tissue until it cannot be ground anymore, and collect it to make a cell suspension; S4, add cell digestion solution to the cell suspension again, and digest at 40 rpm for 45 min at 37°C; S5. Centrifuge the cell suspension at 1000-2000g for 10 min at room temperature, collect the cell pellet, and wash once with 2 mL of phosphate buffer; S6. Discard the supernatant, add red blood cell lysis buffer, lyse red blood cells at 4°C for 15 min, collect cells by centrifugation, and resuspend in PBS phosphate buffer to prepare a cell resuspension solution; S7, take 1-1.5mL of cell resuspension, use 100-150μL of antigen blocking solution to block for 30min at room temperature, and mix by inverting every 10min; S8. Dilute the Ly6C antibody labeled with allophycocyanin (APC) and the DCN antibody labeled with fluorescein isothiocyanate (FITC) with antigen blocking solution at a ratio of 1:50 to prepare the antibody working solution. Add 100-150 μL of the prepared working solution to the cell resuspension solution and stain at 4°C in the dark for 1 h. S9, centrifuge the cell resuspension at 2000 rpm for 10 min, discard the supernatant, wash once with PBS phosphate buffer, and finally resuspend again with 1-1.5 mL PBS phosphate buffer as a sample detection solution, and detect and analyze by flow cytometry, using Ly6C antibody labeled with allophycocyanin (APC) as a fibroblast population marker, and using DCN antibody labeled with fluorescein isothiocyanate (FITC) as a fibroblast subpopulation marker; S10. Using Ly6C antibody and DCN antibody positivity as markers, use a flow cytometer to collect cells that are positive for Ly6C antibody and DCN antibody, and thus the DCN-positive fibroblast subpopulation can be collected.

5. The method for using the mouse fibroblast subpopulation identification reagent composition according to claim 4, characterized in that: The difference between the steps of identifying and sorting lung tissue fibroblast subpopulations of ARDS mice in damaged and repaired states is that in step S8, allophycocyanin (APC)-labeled Ly6C antibody, phycoerythrin (PE)-labeled CyclinD1 antibody and fluorescein isothiocyanate (FITC)-labeled DCN antibody are diluted with antigen blocking solution at a ratio of 1:50 to prepare an antibody working solution.

6. The method for using the mouse fibroblast subpopulation identification reagent composition according to claim 4, characterized in that: The difference between the steps of identifying and sorting fibroblast subpopulations in the lung tissue of ARDS mice in the damaged and repair states is that in step S9, Ly6C antibody labeled with allophycocyanin (APC) is used as a fibroblast population marker, CyclinD1 antibody labeled with phycoerythrin (PE) is used as a damage and repair marker, and DCN antibody labeled with fluorescein isothiocyanate (FITC) is used as a fibroblast subpopulation marker.

7. The method for using the mouse fibroblast subpopulation identification reagent composition according to claim 4, characterized in that: The difference between the steps of identifying and sorting the subpopulations of lung tissue fibroblasts in ARDS mice in a state of injury and repair is that, in step S10, Ly6C antibody, CyclinD1 antibody and DCN antibody positivity are used as markers, and cells positive for Ly6C antibody, CyclinD1 antibody and DCN antibody are collected using a flow cytometer collection tube to identify and sort the subpopulations of lung tissue fibroblasts in a state of injury and repair in ARDS mice.

Citation Information

Patent Citations

  • Microalgae cell wall mutant screening method

    CN109797105A

  • Construction method of pulmonary fibrosis in-vitro model

    CN114891720A

  • Cancer associated fibroblasts recapitulate phenotypes and functions across tumor types and species

    WO2023069652A1